Acquisition momentum AddLife’s active M&A strategy across niche lab and medical segments signals ongoing expansion and potential cross-sell opportunities to newly acquired companies, distributors, and product lines in Europe.

European footprint With operations spanning about 85 subsidiaries and a European market focus, there are multiple regional sales channels and service needs ripe for standardized procurement, integration of equipment, and unified support offerings.

Portfolio synergies Recent acquisitions in diagnostics, patient positioning, refrigeration for pharma/healthcare, and cell biology distribution create cross-selling chances for peripherals, consumables, service contracts, and training across AddLife’s network.

Tech-enabled sales Adoption of platforms like iCIMS, AWS, and marketing tools suggests readiness for lead generation, CRM-driven account mapping, and targeted campaigns to healthcare institutions and laboratories.

North America signals Hiring a North America managing director and existing European orientation indicate potential for regional expansion; explore incentives, distributors, and regulatory-compliant solutions to enter or deepen penetration in the US market.